ror,sponsor_name,sponsor_article,number_of_trials,staff_10_years,indicator_10_years,staff_10_years_drug,indicator_10_years_drug,staff_10_years_last_year,indicator_10_years_last_year,staff_10_years_last_year_drug,indicator_10_years_last_year_drug,staff_10_years_france,indicator_10_years_france,staff_10_years_drug_france,indicator_10_years_drug_france,staff_10_years_last_year_france,indicator_10_years_last_year_france,staff_10_years_last_year_drug_france,indicator_10_years_last_year_drug_france
02vjkv261,Institut national de la santé et de la recherche médicale,de l',93,63,27 %,13,31 %,63,14 %,13,31 %,9703,51 %,3667,76 %,9703,32 %,3667,53 %
